RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

Moderna, Inc. (NASDAQ:MRNA)’s shares came under the investors’ radar after Oracle Chairman Larry Ellison discussed the transformative potential of AI in healthcare during a meeting at the ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early ...

Moderna (MRNA) stock surged 7% this week following Oracle (ORCL) CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer.

Larry Ellison of Oracle and also included Microsoft, NVIDIA and more. "A new American company that will invest $500 billion, at least, in AI infrastructure in the United States, creating over ...

The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.